Miedzyleski Szpital Specjalistyczny W Warszawie

Warsaw 6 trials 3 recruiting

6 Registered trials

3 Currently recruiting

Organisation

Miedzyleski Szpital Specjalistyczny W Warszawie

Location

Warsaw, Poland

Identifier

ORG-100042275

Address

Ul. Bursztynowa 2, 04-749, Poland

Departments

40867:Oddzial Dermatologii Doroslych
Oddzial Nefrologii i Stacja Dializ
Oddział Kardiologii i Chorób Wewnętrznych
Oddział Nefrologiczny i Stacja Dializ
Oddział Nefrologiczny, Stacja Dializ
Odzdział nefrologiczny, Stacja Dializ

Clinical trials at this site (6)

Search interface

A study to learn how safe bimekizumab is and how well it works in adults with palmoplantar pustulosis Recruiting

2024-520337-80-00 Palmoplantar Pustulosis 5 2026-01-07
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney D… Recruiting

2025-523123-22-00 Chronic Kidney Disease 5 2026-05-07
A phase III, randomized, open-label, blinded endpoint, comparative trial of ferric derisomaltose versus no intravenous iron in iron-deficien… Recruiting

2024-519059-28-00 Chronic Heart Failure 5 2025-07-17
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients with IgA Nephropathy at Risk of Progressive Loss of … Ended

2024-513227-16-00 Immunoglobulin A Nephropathy (IgAN) 5 2021-05-19
Effectiveness and Safety of Sparsentan as treatment for Immunoglobulin A Nephropathy (IgAN) Ended

2023-505495-30-00 Immunoglobulin A Nephropathy (IgAN) 5 2019-02-01
Effectiveness and Safety of Sparsentan as treatment for Primary Focal Segmental Glomerulosclerosis (FSGS) Ended

2023-505494-32-00 Focal segmental glomerulosclerosis (FSGS) 5 2018-10-15